Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7348 p537
7 May 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


RFID pilot goes commercial

Aegate Ltd’s anti-counterfeiting radio-frequency identification pilot for medicines is to be developed into a commercial system (PJ, 19 March, p330).

PA Consulting, Aegate’s parent company, is to invest £15m over the next 30 months to bring its scheme — authentication at the point of dispensing — to market.

Aegate’s system reads RFID (radio-frequency identification) tags attached to individual medicine packs. It then matches the tag identification with a central database of product information provided by manufacturers and displays the result. This confirms the identity of the product and provides any other information the maker has provided, including expiry dates and safety warnings. Aegate has been in discussions with pharmacy IT system suppliers with a view to integrating its technology with dispensary systems.

Ian Shepherd, a pharmacist IT consultant, said: “It’s a brilliant idea, but it is a solution looking for a problem. So long as it is 100 per cent accurate it will be worthwhile, but that is the bit that worries me. Who is going to ensure that the [product and database record] matching is 100 per cent accurate?”

Back to Top


©The Pharmaceutical Journal